Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumothorax-II01:27

Pneumothorax-II

627
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
627

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cerebral Dysfunction of a Diving Fisherman After Prophylactic Recompression Treatment: A Case Report.

Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc·2026
Same author

Induction of protective proteins is fundamental to hyperbaric oxygen preconditioning.

Frontiers in cell and developmental biology·2026
Same author

Postflight Pulmonary Barotrauma in a Pilot Without Underlying Disease.

Aerospace medicine and human performance·2025
Same author

Quantum Dots Mediated Crystallization Enhancement in Two-Step Processed Perovskite Solar Cells.

Nano-micro letters·2025
Same author

Association between retinal nerve fiber layer thickness and psychiatric disorders: a mendelian randomization study.

BMC psychiatry·2024
Same author

Case report: tracheobronchial diverticulum, a potential risk for diving?

Frontiers in medicine·2024

Related Experiment Video

Updated: Nov 25, 2025

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
09:36

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device

Published on: September 24, 2020

3.0K

Xuebijing attenuates decompression-induced lung injuries.

Wen-Tao Meng1,2, Long Qing3, Quan Zhou1

  • 1Department of Diving and Hyperbaric Medicine, Naval Special Medicine Center, Naval Medical University, Shanghai, China.

Diving and Hyperbaric Medicine
|December 16, 2020
PubMed
Summary

Xuebijing (XBJ) treatment significantly reduced lung injuries from decompression sickness (DCS) in rabbits. This traditional Chinese medicine may offer a new therapeutic option for DCS-related lung damage by reducing inflammation.

Keywords:
Decompression illnessDecompression sicknessInflammationPulmonary oedema

More Related Videos

Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury
14:48

Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury

Published on: March 21, 2021

5.3K

Related Experiment Videos

Last Updated: Nov 25, 2025

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
09:36

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device

Published on: September 24, 2020

3.0K
Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury
14:48

Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury

Published on: March 21, 2021

5.3K

Area of Science:

  • Physiology
  • Pharmacology
  • Traditional Chinese Medicine

Background:

  • The lungs are critically affected by decompression sickness (DCS).
  • Xuebijing (XBJ), a traditional Chinese medicine, is recognized for treating acute lung diseases.

Purpose of the Study:

  • To investigate the efficacy of Xuebijing (XBJ) in mitigating lung injuries caused by DCS.
  • To evaluate XBJ's impact on inflammatory responses in a rabbit model of DCS.

Main Methods:

  • A simulated air dive (50m for 60 min) was performed on New Zealand white rabbits.
  • Rabbits received intravenous Xuebijing (XBJ) or saline post-decompression.
  • DCS signs, inflammatory markers, lung water content, and TNF-α levels were assessed.

Main Results:

  • XBJ treatment significantly reduced lung injury markers, including lung wet/dry ratio and protein content.
  • XBJ notably inhibited both systemic (IL-1β) and local (TNF-α) inflammatory responses.
  • Histological analysis confirmed amelioration of lung tissue damage.

Conclusions:

  • Xuebijing (XBJ) demonstrates significant benefits in ameliorating DCS-induced lung injuries.
  • The therapeutic effect is likely mediated through the inhibition of systemic and local inflammation.
  • XBJ presents a potential therapeutic candidate for treating decompression-induced lung injuries.